Mumbai: The initial public offering (IPO) of pharma company Corona Remedies opened today for subscription. Investors have the chance to apply for the IPO until 10 December 2025. The company has set a price band of Rs 1,008–1,062 per share. Retail investors must apply for a minimum of 14 shares, which requires an investment of Rs 14,868.

Fully Offer for Sale Issue

Corona Remedies plans to raise Rs 655.37 crore through this IPO. However, it is a fully Offer for Sale (OFS), meaning the proceeds will go to existing shareholders and not to the company. Major shareholders like Sepia Investments, Anchor Partners, and Sage Investment Trust are selling part of their stake in this issue. Read Also ICICI Prudential Asset Management Company Announces Price Band For IPO, Valuing Company At ₹1.07.

See Full Page